On June 17, Xunfei Health (ASX: 02506) announced a strategic collaboration with PT DSST Mas Gemilang, the digital infrastructure technology investment platform under Indonesia's Sinar Mas Group.

The partnership aims to deepen efforts in the artificial intelligence healthcare sector and jointly promote the digital transformation of healthcare across Indonesia and Southeast Asia.

This initiative marks the large-scale international rollout of Xunfei Health's core digital and intelligent healthcare products into the ASEAN region.

Leveraging Indonesia's position as an ASEAN economic hub and a key node in international cooperation frameworks, the company has completed the localization of its full suite of medical AI products.

By utilizing the Sinar Mas Group's established compliance systems and market channel resources, Xunfei Health plans to accelerate market penetration in the region and significantly expand its overseas business growth opportunities.

As a leading domestic medical AI provider, Xunfei Health's products are already deployed across 31 provinces in China.

Its flagship applications, such as the AI Medical Assistant and AI Resident Health Profile, have been featured at the World Health Assembly for two consecutive sessions, demonstrating mature experience in large-scale implementation and international technology export capabilities.

According to the agreement, the collaboration will cover key AI medical business areas including intelligent diagnosis and treatment, public health monitoring, intelligent medical imaging, and healthcare digitization.

The partners will also engage in joint industrial investments, simultaneously developing solutions tailored for the Southeast Asian market and advancing their commercial deployment.